Cargando…
Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta
Suppressyn (SUPYN) is the first host-cell encoded mammalian protein shown to inhibit cell–cell fusion. Its expression is restricted to the placenta, where it negatively regulates syncytia formation in villi. Since its chromosomal localization overlaps with the Down syndrome critical region and the T...
Autores principales: | Sugimoto, Jun, Schust, Danny J., Yamazaki, Tomomi, Kudo, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218086/ https://www.ncbi.nlm.nih.gov/pubmed/35732788 http://dx.doi.org/10.1038/s41598-022-14104-1 |
Ejemplares similares
-
Controlling Trophoblast Cell Fusion in the Human Placenta—Transcriptional Regulation of Suppressyn, an Endogenous Inhibitor of Syncytin-1
por: Sugimoto, Jun, et al.
Publicado: (2023) -
Could the Human Endogenous Retrovirus-Derived Syncytialization Inhibitor, Suppressyn, Limit Heterotypic Cell Fusion Events in the Decidua?
por: Sugimoto, Jun, et al.
Publicado: (2021) -
Suppressyn localization and dynamic expression patterns in primary human tissues support a physiologic role in human placentation
por: Sugimoto, Jun, et al.
Publicado: (2019) -
A novel human endogenous retroviral protein inhibits cell-cell fusion
por: Sugimoto, Jun, et al.
Publicado: (2013) -
Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta
por: Guibourdenche, Jean, et al.
Publicado: (2023)